(Q56772570)
Statements
A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase–primase inhibitors in their mode of interaction with the antiviral target (English)
0 references
25 February 2008
0 references
61
0 references
5
0 references
1044-1047
0 references